Janier M |
[Syphilis (except congenital syphilis)]. |
1999 Aug-Sep |
Ann Dermatol Venereol |
pmid:10530355
|
Schmidtke LM and Carson J |
Induction, characterisation and pathogenicity in rainbow trout Oncorhynchus mykiss (Walbaum) of Lactococcus garvieae L-forms. |
1999 |
Vet. Microbiol. |
pmid:10535774
|
Nicholas KC et al. |
Periadenitis mucosa necrotica recurrens. |
1975 |
J Oral Surg |
pmid:1053656
|
Tobback K et al. |
Micellar electrokinetic capillary chromatography of macrolide antibiotics. Separation of tylosin, erythromycin and their related substances. |
1999 |
J Chromatogr A |
pmid:10536850
|
Maeda K et al. |
[A case of common variable immunodeficiency that responded to long-term erythromycin chemotherapy]. |
1999 |
Nihon Kokyuki Gakkai Zasshi |
pmid:10540836
|
Aoki Y and Kao PN |
Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543746
|
Netherwood T et al. |
Probiotics shown to change bacterial community structure in the avian gastrointestinal tract. |
1999 |
Appl. Environ. Microbiol. |
pmid:10543832
|
Jobe DA et al. |
Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents. |
1999 |
Clin. Diagn. Lab. Immunol. |
pmid:10548588
|
Zallen RD and Curry JT |
A study of antibiotic usage in compound mandibular fractures. |
1975 |
J Oral Surg |
pmid:1055204
|
Watanabe M et al. |
Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo. |
1999 |
Xenobiotica |
pmid:10553724
|
|
Erythromycin and gastroparesis? Off-licence use: uncertain efficacy for a poorly defined disorder. |
1999 |
Prescrire Int |
pmid:10557568
|
Malonza IM et al. |
A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. |
1999 |
J. Infect. Dis. |
pmid:10558945
|
Reeves AR et al. |
Transcriptional organization of the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea. |
1999 |
J. Bacteriol. |
pmid:10559177
|
Denis A et al. |
Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10560728
|
Bauer JF et al. |
Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation. |
1999 |
J Pharm Sci |
pmid:10564073
|
Morel P et al. |
Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris. |
1999 |
Clin. Exp. Dermatol. |
pmid:10564319
|
Matsuoka M et al. |
Cloning and sequences of inducible and constitutive macrolide resistance genes in Staphylococcus aureus that correspond to an ABC transporter. |
1999 |
FEMS Microbiol. Lett. |
pmid:10564793
|
Menezes CM et al. |
In vitro evaluation of erythromycin in chloroquine resistant brazilian P. falciparum freshly isolates: modulating effect and antimalarial activity evidence. |
1999 Jul-Aug |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:10564920
|
Melo-Cristino J and Fernandes ML |
Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens. |
1999 |
Microb. Drug Resist. |
pmid:10566873
|
Mostaghim D and Millard HD |
Bacterial endocarditis: a retrospective study. |
1975 |
Oral Surg. Oral Med. Oral Pathol. |
pmid:1057148
|
Kondo T et al. |
Application of liquid chromatography-turbo ion spray tandem mass spectrometry for quantitative analysis of a potent motilin receptor agonist, EM574, and its metabolites in human plasma. |
1999 |
J. Chromatogr. B Biomed. Sci. Appl. |
pmid:10574195
|
Clarke AE et al. |
Interaction of bile with erythromycin Lactobionate in vitro. |
1975 |
Aust N Z J Med |
pmid:1057910
|
Peng L and Nimni ME |
Delivery of erythromycin to subcutaneous tissues in rats by means of a trans-phase delivery system. |
1999 |
J. Pharm. Pharmacol. |
pmid:10579684
|
Brown MS et al. |
Production of 6-deoxy-13-cyclopropyl-erythromycin B by Saccharopolyspora erythraea NRRL 18643. |
1999 |
J. Antibiot. |
pmid:10580387
|
Kudo S |
[Diffuse panbronchiolitis and erythromycin therapy]. |
1999 |
Nippon Naika Gakkai Zasshi |
pmid:10581765
|
Klausner MA |
Astemizole use with erythromycin. |
1999 |
Ann. Allergy Asthma Immunol. |
pmid:10582723
|
Zarazaga M et al. |
In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582908
|
McCrea J et al. |
Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity. |
1999 |
J Clin Pharmacol |
pmid:10586386
|
Durak H et al. |
Tc-99m erythromycin lactobionate inhalation scintigraphy in parenchymal lung diseases. |
1999 |
Nucl. Med. Biol. |
pmid:10587109
|
Carsenti-Etesse H et al. |
Gradient plate method to induce Streptococcus pyogenes resistance. |
1999 |
J. Antimicrob. Chemother. |
pmid:10588303
|
Marchese A et al. |
Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy. |
1999 |
J. Antimicrob. Chemother. |
pmid:10588306
|
Wilson R et al. |
Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. |
1999 |
J. Antimicrob. Chemother. |
pmid:10588312
|
Panagea S et al. |
Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? |
1999 |
J. Antimicrob. Chemother. |
pmid:10588329
|
Varaldo PE et al. |
Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. |
1999 |
Clin. Infect. Dis. |
pmid:10589905
|
Glass D et al. |
A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris. |
1999 |
Dermatology (Basel) |
pmid:10592405
|
Debbia EA |
[Antibiotic resistance: an always present problem]. |
1999 |
Recenti Prog Med |
pmid:10592734
|
Brixius B et al. |
[Ventricular tachycardia after erythromycin administration in a newborn with congenital AV-block]. |
1999 Nov-Dec |
Klin Padiatr |
pmid:10592929
|
Damkier P et al. |
Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine. |
1999 |
Br J Clin Pharmacol |
pmid:10594487
|
Doumith M et al. |
Interspecies complementation in Saccharopolyspora erythraea : elucidation of the function of oleP1, oleG1 and oleG2 from the oleandomycin biosynthetic gene cluster of Streptomyces antibioticus and generation of new erythromycin derivatives. |
1999 |
Mol. Microbiol. |
pmid:10594828
|
Portillo A et al. |
Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10595574
|
Sugiyama Y et al. |
Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. |
1999 |
Eur. Respir. J. |
pmid:10596699
|
Polk RE et al. |
Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men. |
1999 |
Pharmacotherapy |
pmid:10600086
|
Esposito S et al. |
In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus. |
2000 Jan-Feb |
Chemotherapy |
pmid:10601794
|
Fluhr JW et al. |
In-vitro and in-vivo efficacy of zinc acetate against propionibacteria alone and in combination with erythromycin. |
1999 |
Zentralbl. Bakteriol. |
pmid:10603662
|
Marre R and Trautmann M |
[Community-acquired respiratory tract infections. Current data on the efficacy of various classes of antibiotics and antibiotic resistance of the main prevalent bacteria species]. |
1999 |
Med. Klin. (Munich) |
pmid:10603732
|
Ku YY et al. |
Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives. |
1999 |
J. Antibiot. |
pmid:10604761
|
Ianaro A et al. |
Anti-inflammatory activity of macrolide antibiotics. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10604943
|
Sato Y et al. |
Adjuvant effect of a 14-member macrolide antibiotic on DNA vaccine. |
1999 |
Cell. Immunol. |
pmid:10607432
|
Wang JS et al. |
Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro. |
1999 |
Pharmacol. Toxicol. |
pmid:10608481
|
Honein MA et al. |
Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study. |
1999 Dec 18-25 |
Lancet |
pmid:10609814
|